课题基金 / 基金详情

Emory Molecular and Translational Imaging Center

Emory Molecular and Translational Imaging Center
埃默里分子和转化成像中心
批准号:
7932214
负责人:
Mark Myron Goodman
金额:
$150.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-24 至 2013-08-31

项目摘要

项目成果

Mark Myron Goodman的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In creating the Emory Molecular and Translational Imaging Center (EMTIC), we have built upon a uniquely supportive Atlanta biomedical environment, a flourishing imaging research community across Emory University and the Georgia Institute of Technology (Georgia Tech), and remarkable growth of the Winship Cancer Institute. The vision and mission for EMTIC is a cross-disciplinary scientific, administrative, and educational network that encompasses imaging scientists and basic and clinician scientists working in areas vital to cancer diagnosis and therapeutics. As conceived, EMTIC is the multi-faceted connector that joins disciplines to accelerate innovative methodological developments and foster their rapid clinical translation. Vital to this mission, EMTIC is closely .aligned with strategic and transforming investments in imaging technology, biomarker development, predictive and personalized medicine, and nanotechnology based at Emory and Georgia Tech. Progress in the development and validation of molecular imaging cancer biomarkers will be founded in a structure of three major Research Projects, four Specialized Resources (Cores), investment in Developmental Funds to support Pilot projects, and a focused Career Development Component. The Research Projects include (Project #1) a translational study of prostate cancer patients using [[18]F]FACBC, an amino acid transporter ligand developed at Emory and an example of the bench-to-bedside capabilities of our investigative team. Project #2 will develop and validate selective chemokine PET markers in head and neck cancer. In Project #3 we will evaluate a unique target-specific molecular MRI probe in a breast cancer animal model. Project #4 tests a novel near-infrared (NIR) fluorescent dye in prostate cancer. Specialized Resources for Imaging (Core A), Tracer Development (Core B), Biostatistics, Modeling, and Data Management (Core C), and Animals, Pathology, and Tumor Models (Core D) will provide support for the Research Projects as well as Year 1 and future Pilot Projects. EMTIC will also provide an ideal structure for support of an integrated Career Development Program to equip the future imaging scientist with the interdisciplinary technical and translational skills to specialize in cellular and molecular imaging for cancer care.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PET Imaging Agents for Protoporphyrin IX
  • 批准号:
    10330484
  • 项目类别:
  • 资助金额:
    $21.51万
  • 财政年份:
    2021
  • 负责人:
    Mark Myron Goodman
  • 依托单位:
Imaging Bacterial Infections in Vivo: First in Man Studies
  • 批准号:
    10543621
  • 项目类别:
  • 资助金额:
    $67.7万
  • 财政年份:
    2021
  • 负责人:
    Mark Myron Goodman
  • 依托单位:
Imaging Bacterial Infections in Vivo: First in Man Studies
  • 批准号:
    10611527
  • 项目类别:
  • 资助金额:
    $60.91万
  • 财政年份:
    2021
  • 负责人:
    Mark Myron Goodman
  • 依托单位:
PET Imaging Agents for Protoporphyrin IX
  • 批准号:
    10199473
  • 项目类别:
  • 资助金额:
    $18.26万
  • 财政年份:
    2021
  • 负责人:
    Mark Myron Goodman
  • 依托单位:
国内基金
海外基金
Kidney injury molecular(KIM-1)介导肾小管上皮细胞自噬在糖尿病肾病肾间质纤维化中的作用
  • 批准号:
    81300605
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    23.0万元
  • 批准年份:
    2013
  • 负责人:
    唐琳
  • 依托单位:
Molecular Plant
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
Molecular Plant